Medical Economics January 25, 2024
Tori Whitacre Martonicz

Learn how a new a skin-wearable device and software system called iTempShield could transform infection monitoring for chemotherapy patients, enhancing early detection, and reducing hospitalizations.

For patients undergoing chemotherapy, infection risks are a critical concern. To help address this point, AION Biosystems has developed iTempShield, a skin-wearable device and software system that tracks temperature remotely and accurately. It helps patients and clinicians stay ahead of infections, especially for high-risk populations. iTempShield is a small, quarter-sized wearable device that can be placed on the skin. It is supported by cloud-based software and proprietary algorithms, which enable it to continuously measure body temperature for up to 60 days.

The device is designed for various clinical applications, including oncology, sepsis monitoring, post-surgical infection...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Patient / Consumer, Provider, Technology, Trends, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article